A new clustering of antibody CDR loop conformations

By Benjamin North, A. Lehmann, Roland L. Dunbrack. 2010

387 citations recorded by the source corpus.

Previous analyses of the complementarity determining regions (CDRs) of antibodies have focused on a small number of “canonical” conformations for each loop. This is primarily the result of the work of Chothia and colleagues, most recently in 1997. Because of the widespread utility of antibodies, we have revisited the clustering of conformations of the six CDR loops with the much larger amount of structural information currently available. In this work, we were careful to use a high-quality data set by eliminating low-resolution structures and CDRs with high B-factors or high conformational energies. We used a distance function based on directional statistics and an effective clustering algorithm using affinity propagation. With this data set of over 300 non-redundant antibody structures, we were able to cover 28 CDR-length combinations (e.g., L1 length 11, or “L1-11” in our nomenclature) for L1, L2, L3, H1 and H2. The Chothia analysis covered only 20 CDR-lengths. Only four of these had more than one conformational cluster, of which two could easily be distinguished by gene source (mouse/human; κ/λ) and one purely by the presence and positions of Pro residues (L3-9). Thus using the Chothia analysis does not require the complicated set of “structure-determining residues” that is often assumed. Of our 28 CDR-lengths, 15 of them have multiple conformational clusters including ten for which Chothia had only one canonical class. We have a total of 72 clusters for the non-H3 CDRs; approximately 85% of the non-H3 sequences can be assigned to a conformational cluster based on gene source and/or sequence. We found that earlier predictions of “bulged” vs. “non-bulged” conformations based on the presence or absence of anchor residues Arg/Lys94 and Asp101 of H3 have not held up, since all four combinations lead to a majority of conformations that are bulged. Thus the earlier analyses have been significantly enhanced by the increased data. We believe the new classification will lead to improved methods for antibody structure prediction and design.

Subfields: Molecular Biology, Radiology, Nuclear Medicine and Imaging

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. Jeffrey J. Gray
  2. Yang Zhang
  3. Andriy Kryshtafovych
  4. Brian D. Weitzner
  5. David Baker
  6. Brian G. Pierce
  7. Jens Meiler
  8. Anna Tramontano

In Radiology, Nuclear Medicine and Imaging

  1. Jeffrey J. Gray
  2. Brian G. Pierce
  3. Brian D. Weitzner
  4. Sarel Jacob Fleishman
  5. Sergey Lyskov
  6. Jiye Shi
  7. Konrad Krawczyk
  8. Gideon Lapidoth

Citations in the corpus